NCT05970302
- Conditions
- Bevacizumab, Capecitabine, Colonic Diseases, +16 more
- Locations
-
- Lin Yang Beijing, China
Clinical trial condition
Explore clinical trials studying Metastatic Colorectal Cancer (mCRC). Study availability and eligibility vary by location and protocol.
NCT05970302
NCT07391566
NCT07243938
Not specified
NCT07134205
Not specified
NCT06699836
NCT03829462
NCT05839951
NCT02649790
NCT03511963
NCT05420909